Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Fraser GAM"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Schep DG; Juravinski Cancer Centre, Hamilton, ON L8V 5C2, Canada., Mir T; Juravinski Cancer Centre, Hamilton, ON L8V 5C2, Canada., Fraser GAM; Juravinski Cancer Centre, Hamilton, ON L8V 5C2, Canada., Greenspoon JN; Juravinski Cancer Centre, Hamilton, ON L8V 5C2, Canada.
Publikováno v:
Current oncology (Toronto, Ont.) [Curr Oncol] 2023 Sep 20; Vol. 30 (9), pp. 8602-8611. Date of Electronic Publication: 2023 Sep 20.
Autor:
Cheung MC; Division of Hematology, Department of Medicine, Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada; Canadian Cancer Trials Group, Queens University, Kingston, Canada. Electronic address: matthew.cheung@sunnybrook.ca., Mittmann N; Canadian Cancer Trials Group, Queens University, Kingston, Canada; Department of Pharmacology and Toxicology and Institute for Health Policy Management and Evaluation, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada., Owen C; Foothills Medical Centre and Tom Baker Cancer Centre, Calgary, Canada., Abdel-Samad N; Division of Hematology, The Moncton Hospital, Moncton, Canada., Fraser GAM; Department of Oncology, Juravinski Cancer Centre, McMaster University, Hamilton, Canada., Lam S; Victoria Hospital, Western University, London, Canada., Crump M; Canadian Cancer Trials Group, Queens University, Kingston, Canada; Division of Hematology, Department of Medicine, Princess Margaret Hospital and University of Toronto, Toronto, Canada., Sperlich C; Centre integre de Santé et de Services Sociaux de la Montérégie-Centre, Greenfield Park, Canada., van der Jagt R; Hematology, Ottawa Hospital, University of Ottawa, Ottawa, Canada., Prica A; Canadian Cancer Trials Group, Queens University, Kingston, Canada; Division of Hematology, Department of Medicine, Princess Margaret Hospital and University of Toronto, Toronto, Canada., Couban S; Canadian Cancer Trials Group, Queens University, Kingston, Canada; Queen Elizabeth II Health Sciences Centre, Dalhousie University, Halifax, Canada., Woyach JA; Division of Hematology, The Ohio State University, Columbus, OH., Ruppert AS; Division of Hematology, The Ohio State University, Columbus, OH; Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN., Booth AM; Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN; Department of Quantitative Health Sciences, and Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN., Mandrekar SJ; Department of Quantitative Health Sciences, and Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN., McDonald G; Canadian Cancer Trials Group, Queens University, Kingston, Canada., Shepherd LE; Department of Pharmacology and Toxicology and Institute for Health Policy Management and Evaluation, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada., Yen H; Canadian Cancer Trials Group, Queens University, Kingston, Canada., Chen BE; Canadian Cancer Trials Group, Queens University, Kingston, Canada., Hay AE; Canadian Cancer Trials Group, Queens University, Kingston, Canada; Department of Medicine, Queen's University, Kingston, Ontario, Canada.
Publikováno v:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2021 Nov; Vol. 21 (11), pp. 766-774. Date of Electronic Publication: 2021 Jul 03.
Autor:
Fraser GAM; Juravinski Cancer Centre, McMaster University, Hamilton, Canada., Chanan-Khan A; Division of Hematology, Mayo Clinic Cancer Center, Jacksonville, FL, USA., Demirkan F; Division of Hematology, Dokuz Eylul University, Izmir, Turkey., Santucci Silva R; IEP São Lucas/Hemomed Oncologia e Hematologia, São Paulo, Brazil., Grosicki S; Department of Hematology and Cancer Prevention, School of Public Health, Silesian Medical University, Katowice, Poland., Janssens A; Universitaire Ziekenhuizen Leuven, Leuven, Belgium., Mayer J; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Jihlavska, Brno, Czech Republic., Bartlett NL; Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, USA., Dilhuydy MS; Hopital Haut Leveque, Bordeaux, France., Loscertales J; Hematology Department, Hospital Universitario La Princesa, IIS-IP, Madrid, Spain., Avigdor A; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer and Sackler School of Medicine, University of Tel-Aviv, Tel-Aviv, Israel., Rule S; Department of Haematology, University of Plymouth Medical School, Plymouth, UK., Samoilova O; Nizhny Novogorod Regional Clinical Hospital, Nizhny Novogorod, Russia., Pavlovsky MA; Department of Hematology, Fundaleu, Buenos Aires, Argentina., Goy A; John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, USA., Mato A; Memorial Sloan-Kettering Cancer Center, NY, USA., Hallek M; Department I of Internal Medicine and German CLL Study Group, University of Cologne, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany., Salman M; Janssen Research & Development, Raritan, NJ, USA., Tamegnon M; Janssen Research & Development, Raritan, NJ, USA., Sun S; Janssen Research & Development, Raritan, NJ, USA., Connor A; Janssen Research & Development, Spring House, PA, USA., Nottage K; Janssen Research & Development, Raritan, NJ, USA., Schuier N; Janssen-Cilag, Neuss, Germany., Balasubramanian S; Janssen Research & Development, Spring House, PA, USA., Howes A; Janssen Research & Development, High Wycombe, UK., Cramer P; Department I of Internal Medicine and German CLL Study Group, University of Cologne, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2020 Dec; Vol. 61 (13), pp. 3188-3197. Date of Electronic Publication: 2020 Aug 06.